Record-setting metrics for Chinese Phase III Diabetes Study

Clinical research for diabetes and more

Record-setting metrics for Chinese Phase III Diabetes Study

Access to large markets where clinical trials that can investigate real patient needs, and do so in a rapid fashion, is invaluable for clinical research organisations.  One such example of George Clinical rapid and access to huge markets took place in China, where diabetes patients numbered up to 90 million in 2010, and the most […]

Read More

October 20th, 2016

Hong Kong regulatory process for clinical trials has been revised

New legislation has taken into effect which simplifies the Hong Kong regulatory process for clinical trial application in that country

Read More

March 23rd, 2015

required
required
required
required
I wish to subscribe to George Clinical communications.
required

Add George Clinical to your network